Senzime AB SEZI
OMXSTO · Sweden · Health Technology
SEK 2.74-0.02 (-0.72%)
Market closed· · SEK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · SEK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
UPPSALA, SE / ACCESS Newswire / September 28, 2026 / (STO:SEZI)(OTCQX:SNZZF) - AB today announced that it has strengthened its financing structure through a new SEK 35 million non-dilutive credit facility with a group of institutional investors, including the Segulah and Crafoord groups. The credit facility replaces 's previously communicated credit line arrangement and extends the company's existing credit financing on improved terms, without increasing the total credit facility size.
UPPSALA, SE / ACCESS Newswire / September 24, 2026 / AB (STO:SEZI)(OTCQX:SNZZF) today announced that it has secured another contract with a leading multi-hospital academic health system based in the eastern US. The IDN contract includes an initial deployment of 60 next-generation TetraGraph systems to be used in operating rooms for monitoring patients undergoing anesthesia.
UPPSALA, SE / ACCESS Newswire / August 5, 2026 / Senzime AB (publ) (STO:SEZI)(OTCQX:SNZZF), a leader in precision-based perioperative monitoring solutions, today announced that the U.S. Department of Veterans Affairs (VA) Strategic Acquisition Center ...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.